Role of Acetaldehyde in the Development of Oral Cancer
Dissecting the Role of Acetaldehyde in Oral Carcinogenesis
Masonic Cancer Center, University of Minnesota
170 participants
Jul 8, 2022
INTERVENTIONAL
Conditions
Summary
This is a minimal risk intervention study where healthy volunteers and individuals with Fanconi anemia will consume a single dose of alcohol and provide primarily non-invasive biological samples at various time points. Biospecimens to be collected include saliva, oral cells collected via mouthwash and cheek brush, and urine. The collection of two blood samples (5 mL each) will be optional and banked for future use.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Alcohol dose given orally that will result in a 0.03% blood alcohol concentration (BAC).
Undergo saliva, mouthwash, and cheek brush collection
Undergo breathalyzer testing
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05973656